Rainbow Childrens Medicare Intrinsic Value
Rainbow Childrens Medicare (RAINBOW) median intrinsic value is ₹413.13 from 9 valuation models (range ₹275–₹689), vs current price ₹1377.10 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse RAINBOW cash flow statement for revenue, profit, balance sheet and cash flow data.
RAINBOW Valuation Methods Summary — DCF, Graham Number & P/E
Rainbow Childrens Medicare intrinsic value across 9 models vs current price ₹1377.10 — upside/downside and value range per method. Also explore RAINBOW share price charts to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹413.13 | ₹330.50 - ₹495.76 | -70.0% | EPS: ₹30.36, Sector P/E: 12x |
| Book Value Method | asset | ₹275.42 | ₹247.88 - ₹302.96 | -80.0% | Book Value/Share: ₹161.57, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹413.13 | ₹371.82 - ₹454.44 | -70.0% | Revenue/Share: ₹182.35, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹550.84 | ₹495.76 - ₹605.92 | -60.0% | EBITDA: ₹592.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹550.84 | ₹440.67 - ₹661.01 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹413.13 | ₹371.82 - ₹454.44 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹413.13 | ₹371.82 - ₹454.44 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹688.55 | ₹619.69 - ₹757.40 | -50.0% | ROE: 18.9%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹413.13 | ₹371.82 - ₹454.44 | -70.0% | EPS: ₹30.36, BVPS: ₹161.57 |
RAINBOW Intrinsic Value vs Market Price — All Valuation Models
Rainbow Childrens Medicare fair value range ₹275–₹689 vs current market price ₹1377.10 across 9 valuation models. For current market price and key ratios, visit Rainbow Childrens Medicare share price chart.
RAINBOW Intrinsic Value Analysis — Undervalued or Overvalued?
Rainbow Childrens Medicare median intrinsic value ₹413.13, current price ₹1377.10 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of RAINBOW?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rainbow Childrens Medicare (RAINBOW) is ₹413.13 (median value). With the current market price of ₹1377.10, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹275.42 to ₹688.55, indicating ₹275.42 - ₹688.55.
Is RAINBOW undervalued or overvalued?
Based on our multi-method analysis, Rainbow Childrens Medicare (RAINBOW) appears to be trading above calculated value by approximately 70.0%.
RAINBOW Financial Health — Key Ratios vs Industry Benchmarks
Rainbow Childrens Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.71 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 18.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RAINBOW Cash Flow Quality — Operating & Free Cash Flow
Rainbow Childrens Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹396 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹321 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹327 Cr | ₹95 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹224 Cr | ₹137 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹143 Cr | ₹102 Cr | Positive Free Cash Flow | 8/10 |